Halozyme Therapeutics, Inc.
Cash Flow Statement
| Line Item | FY2009 |
|---|---|
| Operating Activities | |
| Net Income | $-58.4M |
| Depreciation & Amortization | $1.4M |
| Depreciation | — |
| Amortization | — |
| Stock-Based Compensation | $4.5M |
| Net Cash from Operating Activities | $-40.1M |
| Investing Activities | |
| Capital Expenditures | $1.5M |
| Business Acquisitions | — |
| Net Cash from Investing Activities | $-1.5M |
| Financing Activities | |
| Dividends Paid | — |
| Stock Repurchases | — |
| Net Cash from Financing Activities | $45.4M |
| Net Change in Cash | $3.7M |
| Free Cash Flow | $-41.6M |